ViiV Healthcare
Pharmaceutical companyAI in United KingdomAI. FDA records under 3 spellings of its name, each linked to the record.
- Drug applications: 26
- Complete response letters: 2
- Drug recalls: 1
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
Latest Records
Newest first across sources; each opens the record| Date | Record | Source |
|---|---|---|
| Dec 19, 2019 | Complete response letter, NDA 212888Approved | Complete response letters |
| Dec 19, 2019 | Complete response letter, NDA 212887Approved | Complete response letters |
| Feb 11, 2014 | Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, ResearClass III · Cross Contamination with Other Products: Product contains Promacta (eltrombopag). | Drug recalls |
Names and Identifiers
- Appears as
- Website
- viivhealthcare.com
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built